On Tuesday, Coherus Oncology Inc (NASDAQ: CHRS) was 8.75% up from the session before settling in for the closing price of $1.6. A 52-week range for CHRS has been $0.66 – $2.43.
Annual sales at Healthcare sector company slipped by -27.36% over the past five years. When this article was written, the company’s average yearly earnings per share was at -702.46%. With a float of $105.68 million, this company’s outstanding shares have now reached $116.22 million.
Coherus Oncology Inc (CHRS) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Coherus Oncology Inc stocks. The insider ownership of Coherus Oncology Inc is 9.07%, while institutional ownership is 46.58%. The most recent insider transaction that took place on May 23 ’25, was worth 73,881. In this transaction Director of this company sold 99,988 shares at a rate of $0.74, taking the stock ownership to the 0 shares.
Coherus Oncology Inc (CHRS) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.01 earnings per share (EPS) during the time that was better than consensus figure (set at -0.11) by 0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -702.46% per share during the next fiscal year.
Coherus Oncology Inc (NASDAQ: CHRS) Trading Performance Indicators
You can see what Coherus Oncology Inc (CHRS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.43. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.38, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -0.87 in one year’s time.
Technical Analysis of Coherus Oncology Inc (CHRS)
Coherus Oncology Inc (NASDAQ: CHRS) saw its 5-day average volume 0.9 million, a negative change from its year-to-date volume of 1.57 million. As of the previous 9 days, the stock’s Stochastic %D was 23.54%.
During the past 100 days, Coherus Oncology Inc’s (CHRS) raw stochastic average was set at 87.29%, which indicates a significant increase from 50.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1106 in the past 14 days, which was higher than the 0.0802 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4828, while its 200-day Moving Average is $1.0928. Nevertheless, the first resistance level for the watch stands at $1.7967 in the near term. At $1.8533, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.9567. If the price goes on to break the first support level at $1.6367, it is likely to go to the next support level at $1.5333. Assuming the price breaks the second support level, the third support level stands at $1.4767.
Coherus Oncology Inc (NASDAQ: CHRS) Key Stats
There are 116,227K outstanding shares of the company, which has a market capitalization of 202.24 million. As of now, sales total 266,960 K while income totals 28,510 K. Its latest quarter income was 10,250 K while its last quarter net income were 297,770 K.
